Published 8 December 2016
| Technology platform | All |
|---|---|
| Tags | Funding Alert, Rare Diseases |
The ERANET ERARE3 2017 call for application opened on the 5th of December. It is focused on preclinical research in the field of Rare Diseases to develop new treatments based on Cell, Gene or pharmacological therapies.
The following 17 countries intend to participate in this call: Austria, Belgium, Canada (including Quebec), Finland, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Poland, Romania, Spain, Switzerland and Turkey.
Interested persons will find the text of the call here
